VSEE — Vsee Health Income Statement
0.000.00%
- $7.84m
- $16.72m
- $10.42m
- 20
- 41
- 16
- 14
Annual income statement for Vsee Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 6.8 | 7.34 | 6.38 | 5.77 | 10.4 |
Cost of Revenue | |||||
Gross Profit | 5.46 | 5.92 | 4.84 | 3.83 | 7.18 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 6.4 | 7.09 | 8.06 | 7.53 | 73.2 |
Operating Profit | 0.405 | 0.252 | -1.68 | -1.77 | -62.8 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.359 | 0.386 | -1.62 | -1.89 | -59.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.259 | 0.278 | -0.926 | -3.73 | -57.7 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 0.259 | 0.278 | -0.836 | -3.76 | -57.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.259 | 0.278 | -0.836 | -3.76 | -57.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.018 | 0.019 | -0.047 | -0.257 | -1.95 |